6-Bromo-5-methoxy-2-methyl-2H-indazole, 97%, 500mg

2,2,2-Trifluoro-N-[2-(4-fluorophenyl)ethyl]acetamide, 97.0%, 500mg

4-Methylbenzo[b]thiophene-2-carboxylic acid, 95.0%, 250mg

tert-Butyl 4-[(4-fluoro-2-nitrophenoxy)methyl]piperidine-1-carboxylate, 95.0%, 1g

4-Chlorothiophenol, 97.0%, 100g

Tert-butyl ((5-oxopyrrolidin-2-yl)methyl)carbamate, 98%, 25g

Dibenzo[b,d]furan-2,3-diamine, 97%, 250mg

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methoxyphenyl)propanoic acid, 98%, 1g

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22-heptaoxa-4-azatetracosan-24-oic acid, 95%, 5g

Acetohydroxamic Acid>98.0%(T)25g

(3-Bromopropyl)(tert-butyl)sulfane, 95%, 100mg

(R)-3-(tert-Butyl)-4-(2,6-diphenoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 250mg

Monocrotalina, mínimo 99 %, 500 mg, envase de vidrio